What is Withings?
Established in 2008 and headquartered in Issy-les-Moulineaux, France, Withings is a pioneering electronics company that has redefined the intersection of consumer technology and personal wellness. The firm specializes in the design and distribution of connected health devices, including smart scales, hybrid smartwatches, and advanced sleep-tracking systems. By integrating clinical-grade data collection with intuitive user interfaces, Withings has established a robust market position as a key player in the preventative healthcare movement. Their products are engineered to provide actionable insights, bridging the gap between daily lifestyle habits and long-term medical outcomes, thereby serving both individual consumers and enterprise-level health partners.
How much funding has Withings raised?
Withings has raised a total of $93.8M across 3 funding rounds:
Series A
$3.8M
Unspecified
$30M
Series B
$60M
Series A (2010): $3.8M with participation from Ventech Solutions
Unspecified (2013): $30M led by 360 Capital Partners, Ventech Solutions, Idinvest Partners, and Bpifrance
Series B (2020): $60M supported by Idinvest Partners, Bpifrance, Gilde Healthcare, BNP Paribas Développement, ODDO BHF Private Equity, and Adelie Capital
Key Investors in Withings
Idinvest Partners
Idinvest Partners is a mid-market private equity firm founded in 1997, specializing in financing and supporting entrepreneurs across various stages of business development.
Bpifrance
Bpifrance is a French public investment bank that supports companies through every stage of development with credit, guarantees, and equity to foster innovation and international growth.
Gilde Healthcare
Gilde Healthcare is a specialized investment firm managing over 1.4 billion euros, focusing on venture and growth opportunities that enable better care at lower costs.
What's next for Withings?
With the infusion of capital from its latest financing round, Withings is well-positioned to deepen its investment in research and development, particularly in the realms of predictive health analytics and remote patient monitoring. The strategic focus will likely shift toward enhancing the interoperability of its device ecosystem with broader healthcare infrastructure, ensuring that its data-driven insights are seamlessly integrated into professional medical workflows. As the company continues to scale, it will likely prioritize international market penetration and the diversification of its product portfolio to address emerging challenges in chronic disease management and aging-in-place technologies. This strategic roadmap ensures that Withings remains at the forefront of the digital health revolution, leveraging its strong financial foundation to drive sustainable, long-term growth in an increasingly data-centric healthcare environment.
See full Withings company page
